Also from this source

You just read:

Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel

News provided by

Hovione

Dec 13, 2017, 10:46 EST